InvestorsHub Logo
Followers 84
Posts 32612
Boards Moderated 86
Alias Born 03/22/2005

Re: DewDiligence post# 1033

Tuesday, 08/22/2006 7:35:52 PM

Tuesday, August 22, 2006 7:35:52 PM

Post# of 48498
Dew, Yes, getting rich in bioland was my goal also, but unfortunately it didn't work out that way. Owning nearly 1% of GTCB though (as you do), why bother continuing to roll the dice big on bio microcaps? You could just cash out and live off the interest. As we've seen, vast amounts of money can evaporate overnight in this sector, and once it's gone, it's very difficult to get back.

BTW, concerning the MRSA topic, have you checked out Cubist? The stock isn't cheap, but they're a nearly pure play on the resistant staph area (though perhaps too pure a play, since they need to diversify their pipeline). Their very successful antibiotic Cubicin (Daptomycin) also works against Vancomycin resistant staph, and they recently got the label expanded to include endocarditis/bacteremia. Cubicin doesn't work well in the lungs however, so they're also working on a modified version. Anyway, since you seem to be getting interested in the infectious disease area, Cubist is worth checking out, in addition to Idenix, Vertex, Gilead, etc.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News